Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review.

Rajan ChamlagainSangam ShahBasanta Sharma PaudelRoman DhitalBipin Kandel

Published in: Interdisciplinary perspectives on infectious diseases (2021)

Sarilumab is a safe drug with good clinical outcomes in patients with COVID-19 and, hence, could be used as an alternative regimen for the treatment. Further prospective studies exploring the relations with baseline biomarkers of inflammation commonly measured such as C-reactive protein and IL-6 would be necessary for a correlation with the treatment.

Keyphrases

coronavirus disease
sars cov
oxidative stress
combination therapy
adverse drug
case control